Clearside Biomedical (CLSD) executive Ciulla sold 13,700 shares for $20.1K at $1.47 under a 10b5-1 plan
Insider transactions reported
Thomas Ciulla (executive at Clearside Biomedical Inc., CLSD) reported that they sold 13,700 shares for $20.1K at $1.47 on Jan 20, 2023. After these transactions the filing shows 291,890 shares held directly.
- Reporting person
- Ciulla Thomas
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 20, 2023 | Open-market sale (S) | Common Stock1, 2 | -13,700 | $1.47 | $20.1K | 291,890 direct |
Holdings before and after
- Common Stock: 305,590 to 291,890 direct
Footnotes from the filing
- 1. The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction pursuant to a Rule 10b5-1 trading plan.
- 2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.45 to $1.51 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Ciulla report in this CLSD Form 4?
Thomas Ciulla (executive at Clearside Biomedical Inc., CLSD) reported that they sold 13,700 shares for $20.1K at $1.47 on Jan 20, 2023. After these transactions the filing shows 291,890 shares held directly.
How many CLSD shares does Ciulla hold after this filing?
The filing shows 291,890 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this CLSD insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for CLSD
Earlier insider filings at CLSD
- Jan 20, 2023SEC Form 4: Lasezkay George M sold $29,244 worth of shares (20,030 units at $1.46) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 484,577 units (tax liability)
- Jan 20, 2023SEC Form 4: Deignan Charles A. sold $21,045 worth of shares (14,030 units at $1.50) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 363,472 units (withholding tax)
- Jan 11, 2023SEC Form 4: Ciulla Thomas sold $3,515 worth of shares (2,170 units at $1.62) as part of a pre-agreed trading plan, decreasing direct ownership by 0.71% to 305,590 units (tax withholding)
- Jan 6, 2023SEC Form 4 filed by Lasezkay George M
- Jan 6, 2023SEC Form 4 filed by Deignan Charles A.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2016
Follow CLSD and get a push notification the moment its next story breaks.